Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience
Christoph Boss, Catherine Brisbare‐Roch, François Jenck
Journal of Medicinal Chemistry (2009) Vol. 52, Iss. 4, pp. 891-903
Closed Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

High-threshold Ca2+channels behind gamma band activity in the pedunculopontine nucleus (PPN)
Brennon R. Luster, Stasia D’Onofrio, Francisco J. Urbano, et al.
Physiological Reports (2015) Vol. 3, Iss. 6, pp. e12431-e12431
Open Access | Times Cited: 35
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Orexins/hypocretins and orexin receptors in apoptosis: a mini‐review
Marc Laburthe, Thierry Voisin, Aadil El Firar
Acta Physiologica (2009) Vol. 198, Iss. 3, pp. 393-402
Closed Access | Times Cited: 42
Recent Advances in Multicomponent Reaction Chemistry
Christopher Hulme, Muhammad Ayaz, Guillermo Martinez‐Ariza, et al.
(2015), pp. 145-187
Closed Access | Times Cited: 33
The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship
Andrezza K. Kim, Robyn M. Brown, Andrew J. Lawrence
Frontiers in Behavioral Neuroscience (2012) Vol. 6
Open Access | Times Cited: 33
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Closed Access | Times Cited: 26
The orexin receptor OX1R in colon cancer: a promising therapeutic target and a new paradigm in G protein‐coupled receptor signalling through ITIMs
Marc Laburthe, Thierry Voisin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1678-1687
Open Access | Times Cited: 33
Ugi 4-CR/Pictet–Spengler reaction as a short route to tryptophan-derived peptidomimetics
Giordano Lesma, R. Cecchi, Sergio Crippa, et al.
Organic & Biomolecular Chemistry (2012) Vol. 10, Iss. 45, pp. 9004-9004
Closed Access | Times Cited: 30
Pharmacotherapy of insomnia
Octavian C. Ioachimescu, Ali El-Solh
Expert Opinion on Pharmacotherapy (2012) Vol. 13, Iss. 9, pp. 1243-1260
Closed Access | Times Cited: 28
Intracellular mechanisms modulating gamma band activity in the pedunculopontine nucleus (PPN)
Brennon R. Luster, Francisco J. Urbano, Edgar García‐Rill
Physiological Reports (2016) Vol. 4, Iss. 12, pp. e12787-e12787
Open Access | Times Cited: 23
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
Paul J. Coleman, John D. Schreier, Anthony J. Roecker, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 14, pp. 4201-4205
Closed Access | Times Cited: 27
Synthesis and Evaluation of Novel Radioligands for Positron Emission Tomography Imaging of the Orexin-2 Receptor
Norihito Oi, Michiyuki Suzuki, Taro Terauchi, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 16, pp. 6371-6385
Closed Access | Times Cited: 26
Dynein Light Chain Tctex-Type 1 Modulates Orexin Signaling through Its Interaction with Orexin 1 Receptor
David Duguay, Erika Bélanger-Nelson, Valérie Mongrain, et al.
PLoS ONE (2011) Vol. 6, Iss. 10, pp. e26430-e26430
Open Access | Times Cited: 24
Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists
Rong Jiang, Xinyi Song, Purva Bali, et al.
Bioorganic & Medicinal Chemistry Letters (2012) Vol. 22, Iss. 12, pp. 3890-3894
Open Access | Times Cited: 22
Truncated Orexin Peptides: Structure–Activity Relationship Studies
Nadezhda German, Ann M. Decker, Brian P. Gilmour, et al.
ACS Medicinal Chemistry Letters (2013) Vol. 4, Iss. 12, pp. 1224-1227
Open Access | Times Cited: 21
Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
Yu Yoshida, Taro Terauchi, Yoshimitsu Naoe, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 21, pp. 6071-6088
Closed Access | Times Cited: 20
Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors
Fei Liu, Vattoly J. Majo, Jaya Prabhakaran, et al.
Bioorganic & Medicinal Chemistry Letters (2012) Vol. 22, Iss. 6, pp. 2172-2174
Closed Access | Times Cited: 18
Orexin receptor antagonists – a patent review (2010 to August 2014)
Christoph Boss
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 12, pp. 1367-1381
Closed Access | Times Cited: 18
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach
Bibia Heidmann, John Gatfield, Catherine Roch, et al.
ChemMedChem (2016) Vol. 11, Iss. 19, pp. 2132-2146
Closed Access | Times Cited: 17
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists
Paul J. Coleman, John D. Schreier, Georgia B. McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 7, pp. 2311-2315
Closed Access | Times Cited: 18
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists
David A. Perrey, Brian P. Gilmour, Scott P. Runyon, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 10, pp. 2980-2985
Open Access | Times Cited: 17
Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists
Thierry Sifferlen, Christoph Boss, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 5, pp. 1539-1542
Closed Access | Times Cited: 17
Effect of 1-Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin-1 Receptor
David A. Perrey, Nadezhda German, Ann M. Decker, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 599-614
Open Access | Times Cited: 14
Rapid identification of orexin receptor binding ligands using cell-based screening accelerated with magnetic beads
Xin Qi, John Astle, Thomas Kodadek
Molecular BioSystems (2009) Vol. 6, Iss. 1, pp. 102-107
Open Access | Times Cited: 17
Structure–activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2
Thierry Sifferlen, Ralf Koberstein, Emmanuelle Cottreel, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 13, pp. 3857-3863
Closed Access | Times Cited: 13

Scroll to top